Full Text View
Tabular View
No Study Results Posted
Related Studies
Oral Contraceptive and Cardiovascular Risk in PCOS
This study has been completed.
Study NCT00593294   Information provided by Federico II University

First Received on January 4, 2008.   Last Updated on January 14, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Polycystic Ovary Syndrome
More general conditions related to this trial
Adnexal Diseases
Cysts
Endocrine System Diseases
Genital Diseases, Female
Gonadal Disorders
Neoplasms
Ovarian Cysts
Ovarian Diseases
Interventions listed in this trial
Physical exercise
Vitamin, polyvitamins tablets
Additional drug interventions recognized in this trial
Contraceptive Agents
Contraceptives, Oral
Drospirenone
Ethinyl Estradiol
Vitamins
More general drug interventions related to this trial
Aldosterone Antagonists
Contraceptive Agents, Female
Estrogens
Growth Substances
Hormone Antagonists
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Micronutrients
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
Federico II University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services